This is HUGE news! MV140, a sublingual vaccine developed to prevent UTIs, showed REMARKABLE success and safely reduced the risk of recurrent UTIs by UP TO 80%. The vaccine not only reduced risk but also enabled a significant number of participants to be completely UTI-free!🧵⬇️

— Chise 🧬🧫🦠🔬💉🥼🥽 (@sailorrooscout) July 26, 2023